Prognosis of children with virus-associated hemophagocytic syndrome and malignant histiocytosis

Correlation with levels of serum interleukin-1 and tumor necrosis factor

Eiichi Ishii, Shoichi Ohga, T. Aoki, S. Yamada, M. Sako, H. Tasaka, A. Kuwanoe, Masayuki Sasaki, Y. Tsunematsu, K. Ueda

Research output: Contribution to journalArticle

106 Citations (Scopus)

Abstract

To clarify the correlation of cytokine level with the severity and prognosis of children with the hemophagocytic syndrome, we analyzed serum interleukin-1 (IL-1) and tumor necrosis factor (TNF) levels in 26 children with either the virus-associated hemophagocytic syndrome (VAHS, n = 12) or malignant histiocytosis (MH, n = 14). When compared to healthy controls, 13 children had an elevated IL-1 (≥20 pg/ml) and 21 children had an elevated TNF (≥10 pg/ml) level at diagnosis. There was, however, no significant difference in the frequency of these high levels between the patients with VAHS and MH. Neither IL-1 nor TNF levels correlated with other clinical or laboratory findings in either VAHS or MH. Two of the 12 patients with VAHS died of an intracranial hemorrhage and 7 of the 14 patients with MH died despite chemotherapy. The MH patients who had a high TNF level (≥50 pg/ml) had a poorer prognosis than those with a low TNF level (<50 pg/ml; p<0.01). In MH patients, other parameters, such as coagulopathy and lactic dehydrogenase, ferritin and IL-1 levels, did not correlate with prognosis. In 3 patients (2 with VAHS and 1 with MH) analyzed periodically, the change in TNF level was closely associated with the clinical progression or regression of the diseases. Serum cytokine levels may thus be monitored not only for predicting the severity and prognosis of VAHS or MH but also for determining the indications for or timing of chemotherapy. Moreover, TNF may play an important role in the progression of VAHS and MH.

Original languageEnglish
Pages (from-to)93-99
Number of pages7
JournalActa Haematologica
Volume85
Issue number2
DOIs
Publication statusPublished - Jan 1 1991

Fingerprint

Histiocytic Sarcoma
Hemophagocytic Lymphohistiocytosis
Interleukin-1
Tumor Necrosis Factor-alpha
Viruses
Serum
Cytokines
Drug Therapy
Intracranial Hemorrhages
Ferritins
Oxidoreductases
Milk

All Science Journal Classification (ASJC) codes

  • Hematology

Cite this

Prognosis of children with virus-associated hemophagocytic syndrome and malignant histiocytosis : Correlation with levels of serum interleukin-1 and tumor necrosis factor. / Ishii, Eiichi; Ohga, Shoichi; Aoki, T.; Yamada, S.; Sako, M.; Tasaka, H.; Kuwanoe, A.; Sasaki, Masayuki; Tsunematsu, Y.; Ueda, K.

In: Acta Haematologica, Vol. 85, No. 2, 01.01.1991, p. 93-99.

Research output: Contribution to journalArticle

@article{904726abead84298a4157f90c0f1c425,
title = "Prognosis of children with virus-associated hemophagocytic syndrome and malignant histiocytosis: Correlation with levels of serum interleukin-1 and tumor necrosis factor",
abstract = "To clarify the correlation of cytokine level with the severity and prognosis of children with the hemophagocytic syndrome, we analyzed serum interleukin-1 (IL-1) and tumor necrosis factor (TNF) levels in 26 children with either the virus-associated hemophagocytic syndrome (VAHS, n = 12) or malignant histiocytosis (MH, n = 14). When compared to healthy controls, 13 children had an elevated IL-1 (≥20 pg/ml) and 21 children had an elevated TNF (≥10 pg/ml) level at diagnosis. There was, however, no significant difference in the frequency of these high levels between the patients with VAHS and MH. Neither IL-1 nor TNF levels correlated with other clinical or laboratory findings in either VAHS or MH. Two of the 12 patients with VAHS died of an intracranial hemorrhage and 7 of the 14 patients with MH died despite chemotherapy. The MH patients who had a high TNF level (≥50 pg/ml) had a poorer prognosis than those with a low TNF level (<50 pg/ml; p<0.01). In MH patients, other parameters, such as coagulopathy and lactic dehydrogenase, ferritin and IL-1 levels, did not correlate with prognosis. In 3 patients (2 with VAHS and 1 with MH) analyzed periodically, the change in TNF level was closely associated with the clinical progression or regression of the diseases. Serum cytokine levels may thus be monitored not only for predicting the severity and prognosis of VAHS or MH but also for determining the indications for or timing of chemotherapy. Moreover, TNF may play an important role in the progression of VAHS and MH.",
author = "Eiichi Ishii and Shoichi Ohga and T. Aoki and S. Yamada and M. Sako and H. Tasaka and A. Kuwanoe and Masayuki Sasaki and Y. Tsunematsu and K. Ueda",
year = "1991",
month = "1",
day = "1",
doi = "10.1159/000204864",
language = "English",
volume = "85",
pages = "93--99",
journal = "Acta Haematologica",
issn = "0001-5792",
publisher = "S. Karger AG",
number = "2",

}

TY - JOUR

T1 - Prognosis of children with virus-associated hemophagocytic syndrome and malignant histiocytosis

T2 - Correlation with levels of serum interleukin-1 and tumor necrosis factor

AU - Ishii, Eiichi

AU - Ohga, Shoichi

AU - Aoki, T.

AU - Yamada, S.

AU - Sako, M.

AU - Tasaka, H.

AU - Kuwanoe, A.

AU - Sasaki, Masayuki

AU - Tsunematsu, Y.

AU - Ueda, K.

PY - 1991/1/1

Y1 - 1991/1/1

N2 - To clarify the correlation of cytokine level with the severity and prognosis of children with the hemophagocytic syndrome, we analyzed serum interleukin-1 (IL-1) and tumor necrosis factor (TNF) levels in 26 children with either the virus-associated hemophagocytic syndrome (VAHS, n = 12) or malignant histiocytosis (MH, n = 14). When compared to healthy controls, 13 children had an elevated IL-1 (≥20 pg/ml) and 21 children had an elevated TNF (≥10 pg/ml) level at diagnosis. There was, however, no significant difference in the frequency of these high levels between the patients with VAHS and MH. Neither IL-1 nor TNF levels correlated with other clinical or laboratory findings in either VAHS or MH. Two of the 12 patients with VAHS died of an intracranial hemorrhage and 7 of the 14 patients with MH died despite chemotherapy. The MH patients who had a high TNF level (≥50 pg/ml) had a poorer prognosis than those with a low TNF level (<50 pg/ml; p<0.01). In MH patients, other parameters, such as coagulopathy and lactic dehydrogenase, ferritin and IL-1 levels, did not correlate with prognosis. In 3 patients (2 with VAHS and 1 with MH) analyzed periodically, the change in TNF level was closely associated with the clinical progression or regression of the diseases. Serum cytokine levels may thus be monitored not only for predicting the severity and prognosis of VAHS or MH but also for determining the indications for or timing of chemotherapy. Moreover, TNF may play an important role in the progression of VAHS and MH.

AB - To clarify the correlation of cytokine level with the severity and prognosis of children with the hemophagocytic syndrome, we analyzed serum interleukin-1 (IL-1) and tumor necrosis factor (TNF) levels in 26 children with either the virus-associated hemophagocytic syndrome (VAHS, n = 12) or malignant histiocytosis (MH, n = 14). When compared to healthy controls, 13 children had an elevated IL-1 (≥20 pg/ml) and 21 children had an elevated TNF (≥10 pg/ml) level at diagnosis. There was, however, no significant difference in the frequency of these high levels between the patients with VAHS and MH. Neither IL-1 nor TNF levels correlated with other clinical or laboratory findings in either VAHS or MH. Two of the 12 patients with VAHS died of an intracranial hemorrhage and 7 of the 14 patients with MH died despite chemotherapy. The MH patients who had a high TNF level (≥50 pg/ml) had a poorer prognosis than those with a low TNF level (<50 pg/ml; p<0.01). In MH patients, other parameters, such as coagulopathy and lactic dehydrogenase, ferritin and IL-1 levels, did not correlate with prognosis. In 3 patients (2 with VAHS and 1 with MH) analyzed periodically, the change in TNF level was closely associated with the clinical progression or regression of the diseases. Serum cytokine levels may thus be monitored not only for predicting the severity and prognosis of VAHS or MH but also for determining the indications for or timing of chemotherapy. Moreover, TNF may play an important role in the progression of VAHS and MH.

UR - http://www.scopus.com/inward/record.url?scp=0025857198&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025857198&partnerID=8YFLogxK

U2 - 10.1159/000204864

DO - 10.1159/000204864

M3 - Article

VL - 85

SP - 93

EP - 99

JO - Acta Haematologica

JF - Acta Haematologica

SN - 0001-5792

IS - 2

ER -